The proposed training program is the centerpiece in efforts to provide postdoctoral training in laboratory genetics for medical geneticists at Harvard Medical School (HMS). This program has made possible the opportunity to offer training to physicians and scientists in a wide variety of disciplines, enabling them to take advantage of the extraordinarily rich academic environment offered at HMS and its affiliated institutions as well as the greater Boston scientific community. In addition, it has served to promote interactions between investigators and provided a forum for increasing faculty contact with trainees in didactic sessions. The training laboratories of the program have historically been centered at HMS and its affiliated institutions including Brigham and Women's Hospital (BWH), the HMS Department of Genetics, Beth Israel Deaconess Medical Center (BIDMC), Children's Hospital Boston (CHB), Dana Farber Cancer Institute (DFCI), and Massachusetts General Hospital (MGH), and more recently have also included laboratories at the Massachusetts Institute of Technology (MIT). Shortly before the last renewal of this training grant, the Harvard Medical School-Partners HealthCare Center for Genetics and Genomics (HPCGG) was initiated. One of the HPCGG's goals is to facilitate training of the next generation of medical geneticists and the HMS Training Grant in Genetics is an integral component in accomplishing this goal. Most recently, the creation of the Broad Institute of MIT and Harvard has even further enhanced training opportunities for geneticists in Boston. The focus of this training is medical and human genetics, and the program is fully integrated with the HMS American Board of Medical Genetics (ABMG) training program, which is accredited by the ABMG in all areas of training (Clinical Genetics, Ph.D. Medical Genetics, Biochemical Genetics, Cytogenetics, and Molecular Genetics), providing the opportunity for trainees to become active candidates for the certification examination in a discipline(s) of medical genetics in addition to receiving laboratory training for two to three years. Since the last renewal of this T32, we have successfully implemented combined residency training programs in Internal Medicine and Medical Genetics and in Pediatrics and Medical Genetics in addition to subspecialty training in Molecular Genetic Pathology.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007748-32
Application #
7881425
Study Section
Special Emphasis Panel (ZGM1-BRT-5 (PG))
Program Officer
Haynes, Susan R
Project Start
1979-07-01
Project End
2013-06-30
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
32
Fiscal Year
2010
Total Cost
$350,935
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Pectasides, Eirini; Stachler, Matthew D; Derks, Sarah et al. (2018) Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. Cancer Discov 8:37-48
Viswanatha, Raghuvir; Li, Zhongchi; Hu, Yanhui et al. (2018) Pooled genome-wide CRISPR screening for basal and context-specific fitness gene essentiality in Drosophila cells. Elife 7:
Currall, Benjamin B; Chen, Ming; Sallari, Richard C et al. (2018) Loss of LDAH associated with prostate cancer and hearing loss. Hum Mol Genet 27:4194-4203
Arachchi, Harindra; Wojcik, Monica H; Weisburd, Benjamin et al. (2018) matchbox: An open-source tool for patient matching via the Matchmaker Exchange. Hum Mutat 39:1827-1834
Jones, Kelly L; McNamara, Erin A; Longoni, Mauro et al. (2018) Dual diagnoses in 152 patients with Turner syndrome: Knowledge of the second condition may lead to modification of treatment and/or surveillance. Am J Med Genet A 176:2435-2445
Wojcik, Monica H; Schwartz, Talia S; Yamin, Inbar et al. (2018) Genetic disorders and mortality in infancy and early childhood: delayed diagnoses and missed opportunities. Genet Med 20:1396-1404
Rohanizadegan, Mersedeh (2018) Analysis of circulating tumor DNA in breast cancer as a diagnostic and prognostic biomarker. Cancer Genet 228-229:159-168
Demirbas, Didem; Brucker, William J; Berry, Gerard T (2018) Inborn Errors of Metabolism with Hepatopathy: Metabolism Defects of Galactose, Fructose, and Tyrosine. Pediatr Clin North Am 65:337-352
Schwartz, Talia S; Wojcik, Monica H; Pelletier, Renee C et al. (2018) Expanding the phenotypic spectrum associated with OPHN1 variants. Eur J Med Genet :
Zhu, Qihui; High, Frances A; Zhang, Chengsheng et al. (2018) Systematic analysis of copy number variation associated with congenital diaphragmatic hernia. Proc Natl Acad Sci U S A 115:5247-5252

Showing the most recent 10 out of 113 publications